Patent Assignment
Reel/Frame 061348/0949
Release of Security Interest
Recorded: 2022-10-07
Pages: 8
Assignor
WILMINGTON SAVINGS FUND SOCIETY, FSB
Executed: 2022-10-03
Assignee
ASSERTIO THERAPEUTICS, INC.
100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST, ILLINOIS, 60045
Covered Properties
(28)
Tablet Shapes to Enhance Gastric Retention of Swellable Controlled-Release Oral Dosage Forms
Patent:
6,488,962 →
Application:
09/598,061 →
Inhibition of Emetic Effect of Metformin with 5-HT3 Receptor Antagonists
Patent:
6,451,808 →
Application:
09/691,398 →
Optimal Polymer Mixtures for Gastric Retentive Tablets
Manufacture of Oral Dosage Forms Delivering Both Immediate-Release and Sustained-Release Drugs
Shell-And-Core Dosage Form Approaching Zero-Order Drug Release
Methods of Treatment Using a Gastric Retained Losartan Dosage
Gastric Retentive Oral Dosage Form with Restricted Drug Release in the Lower Gastrointestinal Tract
Methods for Treating Vasomotor Symptoms Using Gaba Analogs in a Gastric Retentive Dosage Form
Method of Treating Post-Surgical Acute Pain
Gastric Retentive Extended-Release Dosage Forms Comprising Combinations of a Non-Opioid Analgesic and an Opioid Analgesic
Method of Treating Post-Surgical Acute Pain
Gastric Retentive Pharmaceutical Compositions for Treatment and Prevention of Cns Disorders
Gastric Retentive Extended-Release Dosage Forms Comprising Combinations of a Non-Opioid Analgesic and an Opioid Analgesic
Method of Treating Post-Surgical Acute Pain
Method of Treating Post-Surgical Acute Pain
Gastric Retentive Oral Dosage Form with Restricted Drug Release in the Lower Gastrointestinal Tract
Method of Treating Post-Surgical Acute Pain
Gastric Retentive Dosage Forms for Extended Release of Acamprosate into the Upper Gastrointestinal Tract
Gastric Retentive Extended-Release Dosage Forms Comprising Combinations of a Non-Opioid Analgesic and an Opioid Analgesic
Gastric Retentive Extended-Release Dosage Forms Comprising Combinations of a Non-Opioid Analgesic and an Opioid Analgesic
Dual Drug Dosage Forms with Improved Separation of Drugs
Method of Treating Post-Surgical Acute Pain
Dual Drug Dosage Forms with Improved Separation of Drugs
Shell-And-Core Dosage Form Approaching Zero-Order Drug Release
Gastric Retentive Dosage Forms for Extended Release of Acamprosate into the Upper Gastrointestinal Tract
Gastric Retentive Dosage Forms for Extended Release of Acamprosate into the Upper Gastrointestinal Tract
Fumarate Ester Dosage Forms
Gastric Retentive Pharmaceutical Compositions for Treatment and Prevention of Cns Disorders
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 9, 2013
From: BERNER, BRET; LOUIE-HELM, JENNY
To: DEPOMED, INC.
Reel/Frame 030761/0740 →
Assignment of Assignor's Interest
Jul 11, 2013
From: SHELL, JOHN W.
To: DEPOMED, INC.
Reel/Frame 030779/0318 →
Security Interest
Apr 2, 2015
From: DEPOMED, INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 035355/0039 →
Merger
Sep 11, 2018
From: DEPOMED, INC.
To: ASSERTIO THERAPEUTICS, INC.
Reel/Frame 047322/0843 →
Corrective Assignment to Correct the Application Numbers 09402976, 10196590, 11562002,11562173,12047388,13078575,13541314,13541325, 14747289 Previously Recorded on Reel 047322 Frame 0843. Assignor(S) Hereby Confirms the Merger.
May 7, 2019
From: DEPOMED, INC.
To: ASSERTIO THERAPEUTICS, INC.
Reel/Frame 049110/0550 →
Release of Security Interest
Feb 13, 2020
From: DEERFIELD PRIVATE DESIGN FUND III, L.P., AS COLLATERAL AGENT
To: ASSERTIO THERAPEUTICS, INC. (F/K/A DEPOMED, INC.)
Reel/Frame 051930/0778 →
Security Interest
Jun 3, 2020
From: ASSERTIO THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 052829/0160 →